DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
Active, not recruiting · NCT07265414 · Registry updated 2025-12-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Not stated | 2025-12-04 | NCT07265414 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fondazione Humanitas per la Ricerca | 2 |
| Istituto Clinico Humanitas | 69 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| IRCCS Humanitas Research Hospital | Milan | Italy | 2 |